These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10188141)

  • 41. Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis.
    Ding GQ; Zheng CQ; Bagga SS
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1097-103. PubMed ID: 18025312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of erythromycin for psoriasis vulgaris.
    Polat M; Lenk N; Yalcin B; Gür G; Tamer E; Artuz F; Alli N
    Clin Exp Dermatol; 2007 May; 32(3):295-7. PubMed ID: 17397353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
    Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM
    J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of psoriasis with dithranol cream in general practice.
    Ellis JP; Hindson TC; Hudson PM; Rhodes EL; Vollum DI; Walker AE
    Practitioner; 1984 Feb; 228(1388):219-26. PubMed ID: 6701151
    [No Abstract]   [Full Text] [Related]  

  • 47. [Urinary epidermal growth factor and serum pepsinogen I in patients with duodenal ulcers].
    Kolster J; de Kolster CC; Carvajal A; Castro J; González E; Brasel JA; Callegari C
    G E N; 1993; 47(1):16-21. PubMed ID: 8243967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of severe psoriasis with somatostatin: four years of experience.
    Venier A; De Simone C; Forni L; Ghirlanda G; Uccioli L; Serri F; Frati L
    Arch Dermatol Res; 1988; 280 Suppl():S51-4. PubMed ID: 2900624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of psoriasis.
    Faber EM
    Przegl Dermatol; 1976; (6 Suppl):505-7. PubMed ID: 1032205
    [No Abstract]   [Full Text] [Related]  

  • 50. Old wine in new bottles: the revival of anthralin.
    Harris DR
    Cutis; 1998 Oct; 62(4):201-3. PubMed ID: 9798112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy.
    Flisiak I; Porebski P; Flisiak R; Chodynicka B
    Biomarkers; 2003; 8(5):437-43. PubMed ID: 14602527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tars and anthralins.
    Silverman A; Menter A; Hairston JL
    Dermatol Clin; 1995 Oct; 13(4):817-33. PubMed ID: 8785886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The treatment of psoriasis.
    Watson A
    Aust Fam Physician; 1985 Oct; 14(10):1082-3. PubMed ID: 4084130
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidermal growth factor plasma concentrations in healthy control persons, acute and chronic stress and during pregnancy.
    Svoboda T; Wagner A; Speiser P; Clodi M; Luger A
    Horm Metab Res; 1992 Dec; 24(12):582-4. PubMed ID: 1478618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
    Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
    Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris.
    Anderson KS; Petersson S; Wong J; Shubbar E; Lokko NN; Carlström M; Enerbäck C
    Br J Dermatol; 2010 Nov; 163(5):1085-9. PubMed ID: 20716221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
    Baran A; Świderska M; Bacharewicz-Szczerbicka J; Myśliwiec H; Flisiak I
    Lipids; 2017 Jan; 52(1):51-60. PubMed ID: 27864793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dithranol.
    Mahrle G
    Clin Dermatol; 1997; 15(5):723-37. PubMed ID: 9313971
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
    Baran A; Świderska M; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.
    Baran A; Swiderska M; Flisiak I
    J Dermatolog Treat; 2016; 27(2):114-9. PubMed ID: 26293108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.